NCT01433419View on ClinicalTrials.gov

Open-label Study of TAK-875

PHASE3CompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Diabetes Mellitus
Interventions
DRUG

TAK-875

DRUG

TAK-875

Trial Locations (31)

Unknown

Katori-shi

Niihama-shi

Chikushino-shi

Fukuoka

Onga-gun

Yukuhashi-shi

Hiroshima

Chitose-shi

Sapporo

Koga-shi

Ushiku-shi

Chigasaki-shi

Kamakura-shi

Minamata-shi

Yatsushiro-shi

Sasebo-shi

Kashihara-shi

Okinawa-shi

Izumi-shi

Suita-shi

Fujimi-shi

Shimotsuga-gun

Komatsushima-shi

Bunkyo-ku

Chiyoda-ku

Mitaka-shi

Shibuya-ku

Shinjuku-ku

Toshima-ku

Shunan-shi

Ube-shi

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01433419 - Open-label Study of TAK-875 | Biotech Hunter | Biotech Hunter